Longeveron LLC

IPO

Advancing Cell-Based Therapies for Aging and Disease

Miami, United States · Founded 2017 · $15.0M raised

Headquarters
Miami, Florida
Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M Corporate RoundMar 2026
Rounds
1

About

Longeveron is a clinical-stage regenerative medicine company developing mesenchymal stem cell therapies for aging-related and life-threatening conditions. Its lead product, laromestrocel (Lomecel-B™), is derived from bone marrow of healthy adult donors and is being evaluated in clinical trials for Alzheimer's disease, aging-related frailty, hypoplastic left heart syndrome, and pediatric dilated cardiomyopathy. The company operates a GMP manufacturing facility in Miami, Florida.

Summary

Longeveron LLC is a Biotech company based in Miami, United States, founded in 2017. It has raised $15.0M in total across 1 round, most recently a $15.0M Corporate Round round in Mar 2026. Investors include Coastlands Capital, Janus Henderson Investors and Logos Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2026
$15.0M

Sign up to see all 4 rounds

IPO through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Longeveron LLC on Indexed.vc
<a href="https://indexed.vc/companies/longeveron-llc"><img src="https://indexed.vc/api/badge/company/longeveron-llc" alt="Longeveron LLC on Indexed.vc" width="260" height="76" /></a>